These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27663804)

  • 1. The role of selective estrogen receptor modulators in the treatment of schizophrenia.
    Bratek A; Krysta K; Drzyzga K; Barańska J; Kucia K
    Psychiatr Danub; 2016 Sep; 28(Suppl-1):45-48. PubMed ID: 27663804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Huerta-Ramos E; Iniesta R; Ochoa S; Cobo J; Miquel E; Roca M; Serrano-Blanco A; Teba F; Usall J
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):223-31. PubMed ID: 24342775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.
    Heringa SM; Begemann MJ; Goverde AJ; Sommer IE
    Schizophr Res; 2015 Nov; 168(3):603-13. PubMed ID: 25914107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Usall J; Huerta-Ramos E; Iniesta R; Cobo J; Araya S; Roca M; Serrano-Blanco A; Teba F; Ochoa S
    J Clin Psychiatry; 2011 Nov; 72(11):1552-7. PubMed ID: 21903021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.
    Kulkarni J; Gurvich C; Lee SJ; Gilbert H; Gavrilidis E; de Castella A; Berk M; Dodd S; Fitzgerald PB; Davis SR
    Psychoneuroendocrinology; 2010 Sep; 35(8):1142-7. PubMed ID: 20171784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.
    Pinkerton JV; Stanczyk FZ
    Menopause; 2014 Mar; 21(3):309-19. PubMed ID: 23777900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
    Doran PM; Riggs BL; Atkinson EJ; Khosla S
    J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
    Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
    Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of add-on raloxifene in schizophrenia.
    Raveendranathan D; Shivakumar V; Jayaram N; Rao NP; Venkatasubramanian G
    Arch Womens Ment Health; 2012 Apr; 15(2):147-148. PubMed ID: 22290018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
    Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
    Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene trial in postmenopausal woman with treatment-resistant schizophrenia.
    Tharoor H; Goyal A
    Arch Womens Ment Health; 2015 Oct; 18(5):741-2. PubMed ID: 26189131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiovascular effects of selective estrogen receptor modulators.
    Christodoulakos GE; Lambrinoudaki IV; Botsis DC
    Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective estrogen receptor modulators: the future in menopausal treatment.
    Palacios S
    Minerva Ginecol; 2011 Jun; 63(3):275-86. PubMed ID: 21654612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
    Birzniece V; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E521-7. PubMed ID: 22319035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulators in clinical practice: a safety overview.
    Ellis AJ; Hendrick VM; Williams R; Komm BS
    Expert Opin Drug Saf; 2015 Jun; 14(6):921-34. PubMed ID: 25936229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.